Achiko AG Logo

Achiko AG

A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.

ACHI | SW

Overview

Corporate Details

ISIN(s):
CH0522213468
LEI:
Country:
Switzerland
Address:
Tessinerplatz 7, 8002 Zürich
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Achiko AG was a health technology company that developed aptamer-based diagnostic solutions and companion mobile health applications. Its primary products included AptameX™, a biotechnology division for diagnostics, and Teman Sehat, a digital health passport app. The company focused on creating an ecosystem for COVID-19 management by integrating a rapid, low-cost test with its mobile software. As of July 2023, the company is in liquidation and has been delisted from the Swiss Stock Exchange.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-12-21 06:45
Regulatory News Service
Achiko AG Production and Sales Update
English 13.2 KB
2022-12-21 01:00
Earnings Release
Achiko AG Production and Sales Update
English 11.1 KB
2022-12-21 01:00
Earnings Release
Achiko AG Produktions- und Vertriebsupdate
German 18.3 KB
2022-12-20 18:00
Post-Annual General Meeting Information
2022 Ordinary Shareholders Meeting of Achiko AG: Shareholders adopt all proposa…
English 9.6 KB
2022-12-20 01:00
Post-Annual General Meeting Information
2022 Ordinary Shareholders’ Meeting of Achiko AG: Shareholders adopt all propos…
English 8.0 KB
2022-12-20 01:00
Post-Annual General Meeting Information
Ordentliche Generalversammlung 2022 der Achiko AG: Aktionäre nehmen alle Anträg…
German 8.5 KB
2022-11-25 18:10
Pre-Annual General Meeting Information
Achiko AG issues a convocation notice to its shareholders for its Annual Genera…
English 15.9 KB
2022-11-25 01:00
Pre-Annual General Meeting Information
Achiko AG issues a convocation notice to its shareholders for its Annual Genera…
English 14.4 KB
2022-11-25 01:00
Pre-Annual General Meeting Information
Die Achiko AG lädt ihre Aktionäre zur ordentlichen Hauptversammlung am 20. Deze…
German 14.4 KB
2022-11-17 16:10
Investor Presentation
Achiko AG Announces Corporate Update Webcast
English 16.9 KB
2022-11-17 01:00
Regulatory News Service
Achiko AG Announces Corporate Update Webcast
English 15.1 KB
2022-11-17 01:00
Regulatory News Service
Achiko AG kündigt Webcast zum Unternehmens-Update an
German 15.0 KB
2022-11-16 16:20
Report Publication Announcement
Achiko AG Announces Corporate Update Webcast
English 17.0 KB
2022-11-16 01:00
Regulatory News Service
Achiko AG Announces Corporate Update Webcast
English 15.1 KB
2022-11-16 01:00
Report Publication Announcement
Achiko AG kündigt Webcast zum Unternehmens-Update an
German 14.9 KB

Automate Your Workflow. Get a real-time feed of all Achiko AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Achiko AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Achiko AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HVIVO PLC Logo
A CRO running human challenge trials to test infectious disease vaccines for pharma/biotech clients.
United Kingdom HVO
Iconovo AB Logo
Develops inhaled therapies and patented dry powder inhalers for global pharma partners.
Sweden ICO
IMMUPHARMA PLC Logo
Develops novel peptide therapeutics for autoimmune diseases like Lupus (SLE) and CIDP.
United Kingdom IMM
Inhalation Sciences Sweden AB Logo
Inhalation research instruments and CRO services for preclinical pharma/biotech development.
Sweden ISAB
Initiator Pharma A/S Logo
Clinical-stage firm developing drugs for nervous system disorders like ED & trigeminal neuralgia.
Denmark INIT
IXICO PLC Logo
AI-powered neuroimaging and biomarker analytics for neurological clinical trials.
United Kingdom IXI
J. Molner AS Logo
A CDRO specializing in generic injectable and topical drugs for the North American market.
Estonia JML
LYSOGENE Logo France LYS
Mazaro N.V. Logo
Engineering patented, high-efficiency transmissions for vehicles and industrial drivelines.
Belgium MLMAZ
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR

Talk to a Data Expert

Have a question? We'll get back to you promptly.